• Nenhum resultado encontrado

Rev. dor vol.13 número1 en a01v13n1

N/A
N/A
Protected

Academic year: 2018

Share "Rev. dor vol.13 número1 en a01v13n1"

Copied!
1
0
0

Texto

(1)

5

EDITORIAL

Sociedade Brasileira para o Estudo da Dor

c

Rev Dor. São Paulo, 2012 jan-mar;13(1):5

The system for Brazilian Registration of Clinical Trials (ReBEC) was launched in December 16, 2010. This is a national repository for studies with human beings, available at www.ensaiosclinicos.gov.b, to help transparency and dissemination of clinical trials with humans.

When you register your clinical trial on ReBEC, you make it accessible to national and international scientiic communities

and to society in general, who will have information about health researches involving the use of new drugs and of those al-ready being used in our country, in addition to equipment and surgical procedures or non-drug therapies among others, helping the decision-making process of health managers and professionals.

Clinical trials registry will also decrease the so-called publication bias, that is, it will prevent that only successful trials are published, forcing the publication of clinical trials with unintended results or those where the intervention could even have been harmful.

ReBEC is the result of a joint work of the Ministry of Health, through DECIT, of the Oswaldo Cruz Foundation (FIOCRUZ) and of the Pan-American Health Organization / World Health Organization (PAHO/WHO), through the Latin-American and Caribbean Health Science Information Center (BIREME/PAHO/WHO).

The platform is based on the Open Trials system with technological development led by BIREME, being a multilingual, free, open software compatible with WHO criteria and allowing the primary registry by the countries, so that data are exported to WHO’s International Clinical Trials Registry Platform (ICTRP), reason why ReBEC registries are in Portuguese aiming at the Brazilian audience, and in English, to help their dissemination abroad.

Revista Dor, respecting World Health Organization and International Committee of Medical Journal Editors policies for ical trials registry, and acknowledging its importance for the international dissemination of information on open access clin-ical trials, as from this year will give publication preference to articles generated from clinclin-ical trials previously registered in a Clinical Trials Registry Platform meeting WHO and International Committee of Medical Journal Editors requirements, which can be found in ICTRP’s http://www.who.int/ictrp/en, where the Brazilian Clinical Trials Registry (ReBEC) is included.

Irimar de Paula Posso Editor in Chief

Why should you register your clinical trial!

Referências

Documentos relacionados

So, this study aimed at checking the num - ber of regional analgesia requests and the level of cervical dilatation at analgesia request by parturients with intact

Mean pain intensity evaluated by the numerical scale was 6.7 ± 1.83, which may be considered moderate pain and sensory pain by McGill questionnaire.. CONCLUSION : Moderate and

Inclusion criteria for PFPSG were anterior or retropa- tellar pain exacerbated by at least 3 of the following situations: climbing or descending stairs, crouching for a long

Animals were randomly distributed in three groups: Control Group (CG, n = 6) – animals submitted to right calcaneal tendon trauma and untreated; Group 2 Jump (G2, n = 6)

Treatment with reserpine, fluoxetine or with the as- sociation reserpine-fluoxetine has not interfered with phase I and intermediate phase of formalin test in groups submitted

This study aimed at reviewing major action mechanisms and effects of physical therapy techniques to manage pain.. CONTENTS : There are studies on the action mechan- isms and

A larger number of controlled randomized clinical trials involving chiropractic care is needed, as well as the use of more dependable evaluation methods, to prove its real effects

The laboratory identiication of opioid recep - tors has contributed a lot for this evolution and is the current focus of several researches for the discovery of new receptors